Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Mar 15, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new way to predict how changes in wheelchair seating systems can affect people with neuromuscular diseases. Researchers are developing and testing a scoring system that will help doctors understand which patients might benefit from adjustments to their wheelchairs. The study involves participants from eight different centers, with some helping to create the score and others testing it to make sure it's accurate.

To join the trial, participants need to be at least 18 years old, use a wheelchair for more than four hours a day, and have a neuromuscular disease like Duchenne Muscular Dystrophy or Spinal Muscular Atrophy type II. They should also be able to work with a medical equipment provider and agree to participate in the study. Those who have had recent surgeries, are pregnant or breastfeeding, or have legal guardianship restrictions cannot participate. If you join, you’ll be part of a team that aims to improve wheelchair comfort and mobility for people with similar conditions, and you’ll be closely monitored throughout the trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male or female over the age of 18
• • Daily wheelchair user (more than 4 hours per day)
• • Having a neuromuscular disease such as Duchenne Muscular Dystrophy or Infantile Spinal Muscular Atrophy type II
• • Accompanied by an identified medical equipment provider, able to respond to the recommendations of the clinical team
• • Patient informed and having signed consent.
• Exclusion Criteria:
• • Person who already has a seat change or FR prescription at the time of inclusion
• • Having undergone surgery less than 1 year ago or a fracture
• • Pregnant or breastfeeding women
• • Patient under guardianship or curatorship.